China's demand for Anti-Obesity Drugshas grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

TABLE OF CONTENTS

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II.BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade

Financial and Tax Regulations

Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

Anti-Obesity Drugs Industry Structure
Market Size
Market Growth Drivers
Anti-Obesity Drugs Industry Capacity
Major Producer Facility Locations and Output
Locations
Output
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

Overview
Demand of Anti-Obesity Drugs by Region
Anti-Obesity Drugs Production and Demand
Sibutramine
Major Manufacturers
Supply and Demand
Traditional Chinese Medicine
Major Manufacturers
Supply and Demand
Orlistat
Major Manufacturers
Supply and Demand
Rimonabant
Major Manufacturers
Supply and Demand
Metformin
Major Manufacturers
Supply and Demand
Other Anti-Obesity Drugs

Anti-Obesity Drugs Imports and Exports
Anti-Obesity Drugs Imports
Anti-Obesity r Drugs Exports
Pricing Trend

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

Anti-Obesity Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview
China’s Distribution System
Cough Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications

China’s Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

VII. ANTI-OBESITY DRUGS PRODUCER DIRECTORY

Profiles of Anti-Obesity Drugs Producers and Major Suppliers

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. ANTI-OBESITY TREATMENT DRUGS INDUSTRY ASSESSMENTS

Anti-Obesity Drugs Industry Output
Major Producer Facility Location
Major Anti-Obesity Drugs Producer Output in 2007
Market Share of Key Producers
Major Foreign Investment in China

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

Anti-Obesity Drugs Production and Demand
Demand of Anti-Obesity Drugs by Region in 2004
Major Sibutramine Producer Output and Capacity in 2007
Sibutramine Drugs Production and Demand
Major Traditional Chinese medicine Producer Output and Capacity in 2007 Traditional Chinese Medicine Production and Demand
Major Orlistat Producer Output and Capacity in 2007
Olistat Production and Demand
Rimonabant Production and Demand
Major Metformin Producer Output and Capacity in 2007
Metformin Production and Demand
Other Anti-obesity Drugs Production and Demand
China Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

Anti-Obesity Drugs Industry Output
Major Producer Facility Location
Major Anti-Obesity Drugs Producer Output in 2007
Market Share of Key Producers in 2007
Major Foreign Investment in China

LIST OF CHARTS

I. INTRODUCTION

China’s Anti-Obesity Drugs Capacity, Output, Demand

II. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports

III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

Anti-Obesity Drugs Capacity in China
All kinds of Anti-Obesity Drugs Market Share
Anti-Obesity Drugs Capacity, Output and Demand

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

Total Anti-Obesity Drugs Production and Demand
Total Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

Anti-Obesity Drugs Demand by Market in 2009

VI. MARKETING STRATEGIES

China’s Distribution Channel

MarketsandMarkets.com publishes about 120 report a year across 10 main industries. The reports are exhaustive reports with about 50 micro markets and product segments, about 80 to 100 market data summary tables, 50 short company profiles, market breakdown upto 5 levels, strategic and competitive landscape, patent overview of more than 300 patents.

MarketsandMarkets.com publishes about 120 report a year across 10 main industries. The reports are exhaustive reports with about 50 micro markets and product segments, about 80 to 100 market data summary tables, 50 short company profiles, market breakdown upto 5 levels, strategic and competitive landscape, patent overview of more than 300 patents.